Clinical Trial Update: L-Cysteine in Peritoneal Dialysis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating L-Cysteine in patients undergoing peritoneal dialysis for uremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uremia

Drugs mentioned

• L-cysteine (L-cysteine)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Uremia | Phase 2 | Status: COMPLETED